Key result
Tissue plasminogen activator dosing lacks standardized units, with three different units currently in use, predictably leading to problems in clinical reporting.
Answers are grounded in this paper and cite their sources.
Highlights the need for standardized units for reporting tissue plasminogen activator doses to avoid clinical confusion.
Letters and Corrections1 October 1986International Units for Tissue Plasminogen ActivatorH. R. ROBERTS, M.D.H. R. ROBERTS, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-105-4-627_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: The International Committee on Thrombosis and Haemostasis of the International Society on Thrombosis and Haemostasis is deeply involved in the standardization of hemostatic and fibrinolytic agents. At its recent meeting, concern was expressed about the various units used for tissue plasminogen activator. Three units have been used for reporting the doses of this agent: International Units of urokinase; milligrams; and International Units of tissue plasminogen activator. This situation will predictably lead to problems.In the original studies, partially purified preparations of tissue plasminogen activator were compared in potency to the international standard of urokinase and reported in... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: H. R. ROBERTS, M.D. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDose-ranging study with a new two-chain rt-PA in patients with acute myocardial infarction: A multicenter trialMyocardial infarct artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3 1 October 1986Volume 105, Issue 4Page: 627-627KeywordsHemostaticsThrombosisTissue plasminogen activator ePublished: 1 December 2008 Issue Published: 1 October 1986 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Harold R. Roberts (1986) conducted a letter in Thrombosis. Tissue plasminogen activator was evaluated. Tissue plasminogen activator dosing lacks standardized units, with three different units currently in use, predictably leading to problems in clinical reporting.
Synapse has enriched 10 related papers. Consider them for comparative context: